View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 12, 2021updated 12 Jul 2022 11:22am

THREAD and CureClick announce partnership for trial recruitment

US-based technology and service provider THREAD and CureClick have announced a new partnership to accelerate recruitment for decentralised clinical trials (DCTs).

US-based technology and service provider THREAD and CureClick have announced a new partnership to accelerate recruitment for decentralised clinical trials (DCTs).

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The partnership is focused on engaging social media influencers to increase recruitment outcomes in DCTs.

Influencers can combine THREAD’s platform with CureClick’s more than 100,000 patient activists and advocates network to highlight potentially life-saving DCTs within targeted social media networks.

This helps to achieve increased trial enrollment, retention and satisfaction rates.

CureClick CEO Fabio Gratton said: “We are excited for this partnership to advance recruitment for DCTs.

“THREAD is the leading DCT provider, and by joining forces, we can better fulfill our mission to help life science organisations recruit patients faster while ensuring they have the best possible experience at every step.”

By increasing clinical trial awareness and accelerating patient recruitment, CureClick will enable trusted online community members to find and spread accurate information easily across their social networks.

CureClick patient activists will deliver eligible participants to THREAD’s automated participant recruitment and onboarding solution, through this partnership.

THREAD CEO John Reites said: “We have great admiration for CureClick’s ability to drive exceptional recruitment outcomes through its ambassador network of patient activists.

“Having worked successfully with CureClick on several studies in the past, we are excited to deepen our collective impact on DCTs through a more formal partnership.”

The company recently improved its DCT platform with a configurable, automated participant recruitment and onboarding solution where sponsors and CROs can create patient-facing websites.

These websites guide potential participants through a simple automated recruitment and onboarding process.

CureClick is a community-powered platform that revolutionises the recruitment of participants for clinical trials.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena